No takes yet. Share an insight, caveat, or question.
Randomized trial shows intensive glycemic control reduces ocular surgery risk and costs in type 1 diabetes, indicating durable protection through long-term blood glucose regulation.
A 2015 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: